CN Stock MarketDetailed Quotes

688073 Bide Pharmatech

Watchlist
  • 52.20
  • -0.80-1.51%
Market Closed Mar 7 15:00 CST
4.74BMarket Cap59.25P/E (TTM)

Bide Pharmatech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bide Pharmatech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 1.552B--
--2025/FY-- / 1.333B--
--2024/FY1.102B / 1.173B--
--2023/FY1.092B / 1.131B--
--2022/FY833.832M / 829.160M--
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 1.552B--
--2025/FY-- / 1.333B--
--2024/FY1.102B / 1.173B--
--2023/FY1.092B / 1.131B--
--2022/FY833.832M / 829.160M--

Unlock Free Earnings Estimates

Bide Pharmatech Earnings Reports

  • Bide Pharmaceuticals: 2024 Annual Results Report Announcement

    Feb 25 11:00 ET

  • 2024 Annual Results Express Announcement

    Feb 25 11:00 ET

  • Bide Pharmaceuticals: third quarter report 2024

    Oct 23, 2024 12:00 ET

  • Third Quarter Report 2024

    Oct 23, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    NEW WELLLINK
    871634
    28.08 +30.00%
    VIBO
    871245
    57.69 +29.99%
    MTD
    835579
    32.21 +29.98%
    REFORMER
    833030
    37.03 +29.98%
    Hunan Sundy Science And Technology
    300515
    20.20 +20.02%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Mar 8, 2025

    Strong Buy

    • Strong Buy

      50.00%

    • Buy

      50.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Transferring Securities of Securities
    Transferring Securities of Securities
    Intraday-0.34%
    Finance and Securities Lending
    Finance and Securities Lending
    Intraday-0.34%